GENOMIC HEALTH, INC.: 10-Q filed 2015-11-09
What GENOMIC HEALTH, INC. reported in its quarterly report filed 2015-11-09 (fiscal Q3 2015): 29 published measures, 78 facts as tagged in accession 0001558370-15-002536.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2015-11-09
- Fiscal period
- fiscal Q3 2015
- Accession
- 0001558370-15-002536 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All GENOMIC HEALTH, INC. filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 178,343,000 | USD | |
| At 2014-12-31 | 185,921,000 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 132,529,000 | USD | |
| At 2014-12-31 | 145,513,000 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 28,010,000 | USD | |
| At 2014-12-31 | 29,726,000 | USD | |
| At 2014-09-30 | 37,238,000 | USD | |
| At 2013-12-31 | 33,279,000 | USD |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 16,056,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 5,588,000 | USD | 273 |
Revenue
Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 73,554,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 212,325,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 69,101,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 206,580,000 | USD | 273 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | -225,434,000 | USD | |
| At 2014-12-31 | -194,861,000 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 6,301,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -410,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 129,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 292,000 | USD | 273 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 34,682,000 | USD | |
| At 2014-12-31 | 21,860,000 | USD |
Share-based compensation expense
Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 12,055,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 12,596,000 | USD | 273 |
Operating income or loss
Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -5,438,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -30,939,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -5,835,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -17,640,000 | USD | 273 |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 142,005,000 | USD | |
| At 2014-12-31 | 148,520,000 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 43,520,000 | USD | |
| At 2014-12-31 | 38,338,000 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 5,595,000 | USD | |
| At 2014-12-31 | 6,987,000 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 33,754,000 | USD | |
| At 2014-12-31 | 34,916,000 | USD |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 13,480,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 47,193,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 13,891,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 40,527,000 | USD | 273 |
Accumulated other comprehensive income or loss
Cumulative other comprehensive items after tax, such as translation and unrealized hedging or securities effects. These amounts have not passed through net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,332,000 | USD | |
| At 2014-12-31 | -15,000 | USD |
Other noncurrent assets
Noncurrent assets the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 1,656,000 | USD | |
| At 2014-12-31 | 15,541,000 | USD |
Other noncurrent liabilities
Noncurrent liabilities the filer does not present separately. The composition differs by filer and is described only in the filing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 2,294,000 | USD | |
| At 2014-12-31 | 2,070,000 | USD |
Accrued current liabilities
Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 14,465,000 | USD | |
| At 2014-12-31 | 10,444,000 | USD |
Prepaid expenses and other current assets
Prepayments and other current assets grouped under this concept. The balance is not cash and its composition differs by filer.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2015-09-30 | 10,238,000 | USD | |
| At 2014-12-31 | 9,944,000 | USD |
Pre-tax income or loss from continuing operations
Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -5,542,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -30,983,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -6,133,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -18,033,000 | USD | 273 |
Comprehensive income or loss
Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -22,539,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -29,226,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -6,267,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -18,339,000 | USD | 273 |
Net income available to common stockholders
Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -11,843,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -30,573,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -6,262,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -18,325,000 | USD | 273 |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 16,425,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | 48,594,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | 15,007,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | 44,750,000 | USD | 273 |
Depreciation, depletion and amortization
Combined depreciation, depletion and amortization for the period. A noncash allocation of asset cost, not a measure of maintenance spending.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | 5,076,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 5,197,000 | USD | 273 |
Other nonoperating income or expense
Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | -158,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -207,000 | USD | 273 |
| 2014-07-01 to 2014-09-30 | -345,000 | USD | 92 |
| 2014-01-01 to 2014-09-30 | -537,000 | USD | 273 |
Deferred income tax expense or benefit
The deferred portion of income tax expense or benefit, arising from timing differences. It is not tax paid in the period.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-07-01 to 2015-09-30 | 6,200,000 | USD | 92 |
| 2015-01-01 to 2015-09-30 | -765,000 | USD | 273 |
Change in accounts receivable
The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -1,162,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 1,521,000 | USD | 273 |
Change in accounts payable
The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2015-01-01 to 2015-09-30 | -1,816,000 | USD | 273 |
| 2014-01-01 to 2014-09-30 | 672,000 | USD | 273 |
Inspect the source
- Entity
- GENOMIC HEALTH, INC. / CIK 0001131324
- Captured
- SEC response SHA-256
e1725fd1006eda740bc4fda4f76d146bab3356cc63ba681420df6f196a1caf07
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0001131324.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))